ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,668 | -11.7% | 172 | 0.0% | 0.00% | – |
Q2 2023 | $5,287 | -14.7% | 172 | 0.0% | 0.00% | – |
Q1 2023 | $6,197 | -8.8% | 172 | 0.0% | 0.00% | – |
Q4 2022 | $6,797 | -2.9% | 172 | 0.0% | 0.00% | – |
Q3 2022 | $7,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | +40.0% | 172 | +41.0% | 0.00% | – |
Q1 2022 | $5,000 | – | 122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |